Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.298NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.433NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.561NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.605NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.596NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.565NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.361NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.101NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.478NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.86NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.543NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.139NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.362NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.265NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.585NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.351NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.528NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.91 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.617NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.383NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.95 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.189NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.545NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.482NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.564NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.461NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.486NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.603NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.606NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.601NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.186NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used